Senior Manager
MSD R&D (China) Co., Ltd., China (People's Republic)
Xiaoyi Yu, Ph.D., currently serves as a Senior Manager in Clinical Research-Clinical Pharmacology at MSD. With over eight years of industry experience, he has specialized in preclinical and clinical pharmacology roles within both multinational corporations and biotech firms. In addition, Xiaoyi holds over six years of academic experience in pharmacology and clinical pharmacology. Xiaoyi's educational background includes a Ph.D. from China Pharmaceutical University, followed by postdoctoral training at the University of Houston, Baylor College of Medicine, and MD Anderson Cancer Center in Texas, USA.
Throughout his career, Xiaoyi has notable achievements, including leading a team in biotech to attain significant deliverables such as licensing deals with major companies like Pfizer and EQRx, collaborations with Bayer, and handling regulatory milestones including FDA IND, ODD, BTD, and iPsP submissions. He has also overseen 17 compounds across 35 programs and managed a team handling PPS in the US, focusing on drug screening involving first-in-class MDM2 and PROTACs while utilizing advanced CDX, PDX, and orthotopic models. His contributions to multiple MSD Oncology and Non-oncology programs have been significant, resulting in several new drug approvals. Xiaoyi's work has been widely recognized in scientific circles, with publications including an ESMO, CSCO, and ASCPT poster, 26 peer-reviewed manuscripts with 851 citations, and six patents.